| ERF |
ERF: ETS domain-containing transcription factor ERF |
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
4.48 |
Evidence |
|
| ERF |
ERF: ETS domain-containing transcription factor ERF |
MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
4.48 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
HDAC2 |
HDAC2: Histone deacetylase 2 |
4.48 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
4.48 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
HIRA |
HIRA, DGCR1, HIR, TUPLE1: Protein HIRA |
4.48 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
YWHAH |
YWHAH, YWHA1: 14-3-3 protein eta |
4.48 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
4.48 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
4.48 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
CCNH |
CCNH: Cyclin-H |
4.48 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
DLG1 |
IPI00218729 |
4.48 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
4.48 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
4.48 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
YWHAQ |
YWHAQ: 14-3-3 protein theta |
4.48 |
Evidence |
|
| UNG |
IPI00011069 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
4.48 |
Evidence |
|
| FGA |
IPI00021885 |
HRG |
HRG: Histidine-rich glycoprotein precursor |
4.48 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
4.48 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
4.48 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CSE1L |
CSE1L, CAS, XPO2: Exportin-2 |
4.48 |
Evidence |
|
| CP |
CP: Ceruloplasmin precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
4.48 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
4.48 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
4.48 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
4.48 |
Evidence |
|
| WASPIP |
IPI00552369 |
ESPL1 |
IPI00397474 |
4.48 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
NCOA3 |
IPI00220082 |
4.48 |
Evidence |
|
| EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
GNB2L1 |
Lung cancer oncogene 7 |
4.48 |
Evidence |
|